Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06734793 · ClinicalTrials.gov registry record

Wearable Electronic Breath Sound Sensing Device

A clinical trial of Asthma in Children and Asthma Attack, sponsored by Emory University.

Recruiting
Registry status
10
Enrollment target
1
Study location

NCT06734793: Recruiting study of Asthma in Children and Asthma Attack, sponsored by Emory University.

NCT06734793 is a study of Asthma in Children and Asthma Attack that is actively recruiting participants, run by Emory University. The registered enrollment target is 10 participants, below the 205-participant average among 44 other Asthma in Children trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06734793, a study of Asthma in Children and Asthma Attack, is actively recruiting participants, sponsored by Emory University.

RECRUITING
Registry status
10 participants
Enrollment target
1
Study location

Study Summary

This study will assess the ability of a wearable stethoscope to monitor wheezing in high-risk asthma patients admitted at Children's Healthcare of Atlanta. This study is important to assist in the health management of patients with chronic lung diseases that can experience exacerbations leading to their health worsening and requiring hospitalization. The population that will be approached for this study will include 10 pediatric subjects hospitalized at Children's Healthcare of Atlanta for an asthma-related exacerbation. Participants will wear the patches for up to 8 hours on their chest and back wall from their date of consent until their hospital discharge. This may range from the participant taking part in 1 to 14 visits that could last up to 8 hours.

Primary Outcome

CRS is a 12-point assessment used to evaluate respiratory distress in hospitalized patients and guide treatment for asthma and bronchiolitis. It measures factors such as respiratory rate, work of breathing, wheezing, hypoxia, dyspnea, and cough. The change in CRS score will be recorded at the beginning and end of each session and later correlated with changes in breath sound recordings from the device. The absolute change in CRS will be correlated with changes in the breath sound recordings.

Interventions

  • DEVICE Wearable stethoscope
  • OTHER Routine Clinical lung Auscultation

Study Locations (1)

Georgia

  • Arthur M. Blank Hospital | Children's Healthcare of Atlanta - Atlanta

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2025-02-26
Est. Completion 2026-03-01
Emory University

1,208 total trials

What NCT06734793 shows while recruiting

NCT06734793 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 205-participant average among 44 other Asthma in Children trials with a reported enrollment target (95% lower).

The record links to 2 conditions, with Asthma in Children appearing as the primary indexed condition, and to 2 interventions - of which Wearable stethoscope is the first listed.

NCT06734793 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT06734793 about?

NCT06734793 is a clinical study titled "Wearable Electronic Breath Sound Sensing Device". This study will assess the ability of a wearable stethoscope to monitor wheezing in high-risk asthma patients admitted at Children's Healthcare of Atlanta. This study is important to assist in the health management of patients with chronic lung diseases that can experience exacerbations leading to ...

What is the current status of trial NCT06734793?

This trial is currently recruiting. The enrollment target is 10 participants. The study started on 2025-02-26. Estimated completion is 2026-03-01.

What conditions does trial NCT06734793 study?

This clinical trial studies the following conditions: Asthma in Children, Asthma Attack.

What interventions are being tested in trial NCT06734793?

The interventions under investigation include: Wearable stethoscope (DEVICE), Routine Clinical lung Auscultation (OTHER).

Who is sponsoring clinical trial NCT06734793?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06734793 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Asthma in Children

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06734793's enrollment target sits among peer trials

10 44th of 44 higher than 1 of 44 other Asthma in Children trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Asthma in Children trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06734793, the US trial registry maintained by the National Library of Medicine. NCT06734793 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.